1. Home
  2. BGS vs CBIO Comparison

BGS vs CBIO Comparison

Compare BGS & CBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B&G Foods Inc.

BGS

B&G Foods Inc.

HOLD

Current Price

$4.49

Market Cap

357.5M

ML Signal

HOLD

CBIO

Crescent Biopharma Inc.

HOLD

Current Price

$10.00

Market Cap

389.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGS
CBIO
Founded
1996
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
357.5M
389.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BGS
CBIO
Price
$4.49
$10.00
Analyst Decision
Sell
Strong Buy
Analyst Count
4
6
Target Price
$4.38
$27.17
AVG Volume (30 Days)
1.7M
165.4K
Earning Date
02-24-2026
02-23-2026
Dividend Yield
17.39%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,840,699,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.67
$9.43
52 Week High
$8.06
$21.40

Technical Indicators

Market Signals
Indicator
BGS
CBIO
Relative Strength Index (RSI) 54.98 32.50
Support Level $4.25 $9.43
Resistance Level $4.48 $14.71
Average True Range (ATR) 0.15 1.19
MACD 0.03 -0.30
Stochastic Oscillator 83.93 5.30

Price Performance

Historical Comparison
BGS
CBIO

About BGS B&G Foods Inc.

B&G Foods Inc is an American packaged-food manufacturer. It operate in a single industry segment and manufacture, sell and distribute a diverse portfolio of high-quality shelf-stable and frozen foods across the United States, Canada and Puerto Rico. Its products include frozen and canned vegetables, vegetable, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, wine vinegar, The company's main brands are Ac'cent, B&G, B&M, Baker's Joy, Bear Creek Country Kitchens, Cary's, Cream of Rice, Cream of Wheat, Devonsheer, Don Pepino, Durkee, Emeril's, Grandma's Molasses, MacDonald's.

About CBIO Crescent Biopharma Inc.

Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent believes CR-001 has the potential to deliver improved clinical efficacy and safety over pembrolizumab. CR-001 is a new molecular entity designed to replicate the functional properties of ivonescimab, a cooperative bispecific anti-PD-1/anti-VEGF antibody in development by Akeso Biopharma and Summit Therapeutics that delivered improved efficacy in a head-to-head Phase 3 clinical trial versus Keytruda in non-small cell lung cancer. Crescent is advancing its second and third programs, CR-002 and CR-003, which are antibody drug conjugates (ADCs) against validated oncology targets.

Share on Social Networks: